US Corporates Show Deep Q2 Divergence as Health Care and Real Estate Lift Forecasts

US corporate performance is showing deep divergence in the second quarter of 2026, with health-care and retail real estate operators lifting guidance, while select consumer brands and small-cap firms navigate structural overhauls and new funding rounds, according to data compiled by industry analysts.

Institutional fund flows this year have increasingly tilted toward sectors demonstrating resilient cash flows and pricing power amid broader macroeconomic recalibrations, people familiar with the market positioning said.

HCA Healthcare (HCA.US)

Shares of HCA Healthcare have outperformed the broader market recently. The hospital operator reported second-quarter 2026 revenue of USD 20.23 billion, up 8.7% year-over-year, alongside net income of USD 1.69 billion. The company faced a USD 400 million pre-tax headwind due to an increase in uninsured patients following changes to Affordable Care Act exchanges, according to the earnings release. Same-facility admissions rose 2.5%, and the board declared a quarterly cash dividend of USD 0.78 per share.

Brixmor Property Group (BRX.US)

The real estate investment trust has seen its shares advance year-to-date. Brixmor reported second-quarter total revenue of USD 354.2 million, with same-property net operating income growing by 5.8%. Management raised its full-year 2026 forecast, targeting same-property NOI growth of 5.0% to 5.75%. The company also achieved a record 92.6% occupancy rate for its small shop portfolio, signing 1.4 million square feet of new and renewal leases, the company said.

e.l.f. Beauty (ELF.US)

Shares of e.l.f. Beauty rebounded in recent weeks. For the fiscal fourth quarter ended March 2026, the company posted a 35% surge in net sales to USD 449.3 million and expanded its gross margin to 73%. The cosmetics maker is targeting fiscal 2027 net sales growth of 12% to 14%, with adjusted EBITDA projected between USD 379 million and USD 385 million. Its rhode brand recently announced a global expansion into Mexico and seven European markets.

Zhongchao (ZCMD.US)

The US-listed medical information platform has traded sideways after a recent pullback. In late July 2026, the company announced the pricing of a USD 5 million registered direct offering, following a 1-for-3 reverse stock split executed in June. For fiscal year 2025, Zhongchao reported annual revenue of USD 11.37 million, a year-over-year decline of 28.3%, according to its filings.

Under Armour (UAA.US)

Under Armour has faced downward pressure on its shares this year amid weakening fundamentals. The athletic apparel maker has seen revenue decline over the past two years on a constant currency basis. To stabilize its operations, the company is targeting USD 5.3 billion in revenue and USD 182.1 million in profit by 2029, a goal that requires an annual top-line growth rate of 2.2%, analysts noted. The company also recently appointed a new global brand ambassador to revamp its marketing.

Carnival (CCL.US)

Shares of Carnival have been influenced by shifting consumer travel spending in 2026. As one of the world's largest leisure travel companies, investors are closely monitoring its forward booking volumes and debt reduction progress for the second half of the year, according to market watchers.

JetBlue Airways (JBLU.US)

JetBlue Airways has lagged behind some legacy carriers this year as it navigates domestic capacity gluts. The airline's management is currently focused on optimizing its network and controlling operational costs to offset pricing pressures in the US leisure travel market.

DBS Group (DBSDY.US)

The Singapore-based financial services group has seen its US-traded ADRs maintain steady trading ranges. Amid the current shift in global interest rate policies, analysts are zeroing in on the bank's net interest margin trajectory and wealth management inflows for the remainder of 2026.

Vista Gold (VGZ.US)

Shares of Vista Gold have largely tracked the elevated volatility of international gold prices in 2026. Market participants are tracking the timeline and capital efficiency of the miner's flagship development projects to gauge its long-term valuation potential.

Industrial Select Sector SPDR Fund (XLI.US)

As a proxy for the broader US industrial base, the ETF has consolidated in recent trading sessions. The fund's performance reflects the ongoing mixed signals in US manufacturing data and capital expenditure trends heading into the third quarter.

This article does not constitute investment advice.